Title: Anatomical and functional changes
after aortic valve replacement with different sizes
of mechanical valves
Authors: Gokhan Ilhan, Sahin Bozok, Berkan
Ozpak, Hakan Kara, Serkan Yazman, Serdar Bayrak,
Ibrahim Ozsoyler, Ali Gurbuz
From: Cardiovascular Journal of Africa, Vol 29,
Issue 6 November/December
Published: 2018
Pages: 338–343
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2018-037
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2018-037
Objective: To date, there is no consensus on the
selection of type and size of prosthetic valve for
aortic valve replacement (AVR). The aim of this
study was to compare anatomical and functional
changes occurring in the left ventricle after AVR
with different sizes of mechanical valves.
Methods: A total of 92 patients with serious aortic
valve stenosis, who underwent AVR between March 2001
and June 2008 using mechanical valves of different
sizes, were retrospectively analysed. The sizes of
the mechanical valves were 19, 21, 23 and 25 mm. All
patients were assessed preoperatively, and at six
months and in the first, third and fifth years
postoperatively. The left ventricle was assessed
with electrocardiography, echocardiography and
telecardiography and compared in the four patient
groups, constituted according to the mechanical
valve size used.
Results: In all groups, left ventricular mass and
mass index, transvalvular aortic gradient,
thicknesses of the interventricular septum and
posterior wall, and left ventricular endsystolic and
end-diastolic diameters had decreased significantly
post surgery. Left ventricular ejection fraction and
exercise capacity had increased significantly (p <
0.001). The most noteworthy anatomical and
functional improvements were seen in patients who
had received 23- and 25-mm mechanical valves.
Conclusion: Mechanical valve replacement should not
be performed with small size valves because of the
higher residual gradient.
Title: Prevalence and
sociodemographic correlates of cardiovascular
risk factors among patients with hypertension in
South African primary care
Authors: JM Ngango, OB Omole
From: Cardiovascular Journal of Africa, Vol 29,
Issue 6 November/December
Published: 2018
Pages: 344–351
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2018-038
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2018-038
Objective: To determine the prevalence and
sociodemographic correlates of cardiovascular
risk factors among patients with hypertension at
Johan Heyns Community Health Centre, Sedibeng
district, South Africa.
Methods: A total of 328 participants were
systematically sampled. A
researcher-administered questionnaire collected
information on: socio-demography, presence of
diabetes, family history of
hypercholesterolaemia, family history of fatal
cardiovascular (CV) events, and engagement in
physical activities. Other measurements
included: blood pressure (BP), weight, height,
abdominal circumference and electrocardiography
(ECG). Data analysis included descriptive
statistics, chi-squared test and regression
analysis. Main outcome measures included the
proportions of participants with each CV risk
and their significant sociodemographic
determinants.
Results: Participants’ mean age was 57.7 years.
Most participants were black (86.0%), female
(79%) and pensioners (43.6%). The mean BP was
139/84 mmHg, and 60.7% had their BP controlled
to targets. There was an average of 3.7 CV risk
factors per participant and the prevalence of CV
risk factors was: abdominal obesity (80.8%),
physical inactivity (73.2%), diabetes (30.2%),
alcohol use (28.0%), hypercholesterolaemia
(26.5%), smoking (11.9%), past family history of
fatal CV event (14.9%), and left ventricular
hypertrophy (5.2%). Sociodemographic factors
significantly associated with each CV risk
factor were: obesity and being female (p =
0.00); alcohol use and young age (p = 0.00);
smoking, being male and race other than black (p
= 0.00 and p = 0.00, respectively); physical
inactivity, being a pensioner and male (p = 0.02
and p = 0.02, respectively); diabetes and being
male (p = 0.03); hypercholesterolaemia and race
other than black (p = 0.03); family history of
hypercholesterolaemia and race other than black
(p = 0.00); and family history of fatal CV event
and race other than black (p = 0.00).
Conclusion: There is a high burden of CV risk
factors among patients with hypertension in
South African primary care, signifying a
substantial risk of cardiovascular disease (CVD)
in this setting. Interventions aimed at CVD risk
reduction need to take cognisance of the
sociodemographic correlates of CV risk factors.
Title: Usefulness of a titration
algorithm for de novo users of
sacubitril/valsartan in a tertiary centre heart
failure clinic
Authors: Émilie Laflamme, Audrey Vachon, Sylvain
Gilbert, Julie Boisvert, Vincent Leclerc,
Mathieu Bernier, Pierre Voisine, Mario Sénéchal,
Sébastien Bergeron
From: Cardiovascular Journal of Africa, Vol 29,
Issue 6 November/December
Published: 2018
Pages: 352-356
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2018-039
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2018-039
Background: A reduction in the rate of death and
hospitalisations in patients with heart failure
(HF) with reduced ejection fraction receiving
sacubitril/valsartan compared to enalapril was
demonstrated in the PARADIGM-HF study. However,
tolerability when initiating and optimising
sacubitril/valsartan treatment in real clinical
practice is unknown.
Methods: We performed a prospective cohort study
of clinical and biochemical parameters of the
first 100 patients receiving
sacubitril/valsartan in a tertiary HF clinic.
Patients had titration of the molecule guided by
an algorithm developed by pharmacists and
cardiologists in the clinic. The objective was
to evaluate the proportion of patients reaching
the maximal dosage, the time to reach maximal
dosage, and the rate of adverse events, as well
as the required modification of other HF therapy
during the sacubitril/valsartan titration.
Results: Forty-six per cent of patients reached
the sacubitril/ valsartan maximal dose of 97/103
mg (200 mg) twice daily and 73% received at
least 49/51 mg (100 mg) twice daily. Mean
titration time was 30 ± 9 days. Symptomatic
hypotension, renal dysfunction (increase in
creatinine level > 30%) and hyperkalaemia
(potassium level > 5.5 mmol/l) occurred in nine,
four and 2% of patients, respectively.
Background HF pharmacological treatment remained
stable during the sacubitril/valsartan titration
but daily dosage of furosemide was reduced by
13% (p = 0.0005).
Conclusions: This algorithm is a safe and
easy-to-use tool in daily clinical practice for
the introduction and titration of
sacubitril/valsartan. Almost half of the
patients reached the maximal dose, with a
tolerability profile in line with the original
study.
Title: The efficacy of antiplatelet therapies as evaluated by
thrombo-elastography in retired Chinese officersAuthors: Yongzeng Chen,
Xi Wang, Qian Yu, Fan Wang, Haijun Wang, Hongbin Liu
From: Cardiovascular Journal of Africa, Vol 29,
Issue 6 November/December
Published: 2018
Pages: 357–361
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2018-041
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2018-041
Aim: This study evaluated, using
thrombo-elastography (TEG), the efficacy of antiplatelet therapies in retired
Chinese officers and explored the factors influencing the efficacy of
antiplatelet therapies.
Methods: Nine hundred and fifty-five retired male Chinese officers (≥ 60 years
old), who had undergone TEG between June and August 2015 at the Chinese People’s
Liberation Army General Hospital (PLAGH), were enrolled in this study. The
subjects were divided into four groups according to the antiplatelet drug(s)
that they were administered: aspirin, clopidogrel, dual drugs (combination of
aspirin and clopidogrel) and no antiplatelet drug. TEG was used to evaluate the
efficacy of antiplatelet therapy in the four groups.
Results: The inhibition of platelet aggregation induced by arachidonic acid
(AA%) was 48.0 ± 19.3% in the aspirin group, and the inhibition induced by
adenosine diphosphate (ADP%) was 63.0 ± 18.2% in the clopidogrel group. The AA%
and ADP% in the dual-drug group were 51.0 ± 16.5 and 46.0 ± 15.3%, respectively.
The total efficacy of antiplatelet therapy was 45.9% in the aspirin group, 51.2%
in the clopidogrel group and 81.4% in the dual-drug group. A multivariate
logistic regression analysis of the maximum amplitude of ADP-induced
platelet–fibrin clot strength (MA-ADP) indicated that in the population with
MA-ADP < 31 mm, an increased white blood cell count (OR = 1.262, p < 0.001) was
a risk factor, while an increased platelet count (OR = 0.995, p = 0.013) was a
protective factor for bleeding. In the population with MA-ADP > 47 mm, increased
platelet count (OR = 1.006, p < 0.001), estimated glomerular filtration rate
(eGFR, OR = 1.016, p = 0.013) and glycated haemoglobin levels (HbA1c, OR =
1.358, p = 0.011) were risk factors for thrombosis.
Conclusion: This quality-controlled TEG procedure was an efficient method to
evaluate the efficacy of antiplatelet therapies in the clinic. White blood cell
and platelet counts, and eGFR and HbA1c levels may influence the efficacy of an
antiplatelet therapy.
Title: Evaluation of ventricular arrhythmogenesis in children with
acute rheumatic carditis Authors: Mehmet Kucuk, Cem Karadeniz,
Rahmi Ozdemir, Timur Meşe
From: Cardiovascular Journal of Africa, Vol 29,
Issue 6 November/December
Published: 2018
Pages: 362–365
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2018-043
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2018-043
Background: Recent studies have shown that the
Tp-e interval, which on an electrocardiogram (ECG) is the interval between the
peak and the end of the T wave, can be used as an index of transmural dispersion
of ventricular repolarisation (TDR). Both Tp-e/QT and Tp-e/QTc ratios have also
been used in that capacity. However, these novel repolarisation indices have not
previously been studied in children with acute rheumatic carditis (ARC).
Methods: A hundred and thirty-nine children who were diagnosed with ARC and 153
age- and gender-matched healthy controls were retrospectively reviewed.
Twelve-lead ECGs were used to evaluate P-wave, QT and QTc dispersions, Tp-e
interval, and Tp-e/QT and Tp-e/QT ratios.
Results: The mean age of the patients was 10.9 ± 2.4 years. The P-wave, QT and
QTc dispersions were significantly higher in patients compared to the healthy
control subjects. The Tp-e interval, and Tp-e/QT and Tp-e/QTc ratios were also
significantly increased in patients compared to the controls. When the patients
were compared in terms of either one- or twovalve involvement, we found no
difference between the groups regarding P-wave, QTd and QTc dispersions, Tp-e
interval, and Tp-e/QT and Tp-e/QTc ratios. There was no correlation between
acute-phase reactants, white blood cell count and these repolarisation
parameters.
Conclusions: This study showed that the new transmural dispersion of ventricular
repolarisation parameters, Tp-e interval, Tp-e/QT ratios and QTd were increased
in children with ARC. Prolongation of the Tp-e interval and an increased Tp-e/QT
ratio might be useful markers for predicting myocardial involvement in children
with ARC.
Title: TCultural coping as a risk
for depression and hypertension: the SABPA
prospective study Authors: S Le Roux, GA Lotter, HS
Steyn, L Malan
From: Cardiovascular Journal of Africa, Vol 29,
Issue 6, November/December
Published: 2018
Pages: 366–373
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2018-045
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2018-045
Objectives: In past studies, a lack of social
support has been associated with cardiovascular
disease (CVD) risk, particularly in black
Africans. However, whether or not coping
strategies have beneficial effects on blood
pressure (BP) and emotional well-being is not
clear. We therefore assessed the relationship
between BP levels, depression and coping
strategies.
Methods: A prospective bi-ethnic cohort followed
359 black and white South African school
teachers (aged 20–65 years) over a three-year
period. Data on ambulatory 24-hour blood
pressure, depression, coping strategies
(defensiveness, social support, avoidance) and
culture-specific coping scores (cognitive/
emotional debriefing, spiritual-, collectivistic
and ritualcentred) were obtained.
Results: Over three years, chronic depression
(38 vs 19%) and hypertension (68 vs 35%) were
apparent in blacks (d-values > 0.3) as opposed
to whites. In both groups, depression was
accompanied by more avoidance (loss-of-control)
coping. Consistent spiritual and increasing
collectivistic coping were apparent in whites.
Over time, increasing defensiveness (OR 1.08, p
≤ 0.05) and ritual coping (OR 1.27, p ≤ 0.01;
d-values > 0.5), predicted chronic depression in
blacks. The change in their symptoms of
depression predicted 24-hour hypertension (OR
1.11, p = 0.04). No similar associations existed
in whites.
Conclusions: Blacks showed increasing
defensiveness and ritual- and spiritual-centred
coping in an attempt to combat chronic
depression, which may be costly, as reflected by
their chronic hypertensive status. Whites showed
consistent spiritual- centred coping while
utilising avoidance or loss-of-control coping,
with a trend of seeking less social support or
isolation as a coping mechanism. During
counselling of depressed patients with
hypertension, the beneficial effects of social
support and spiritual coping may be of great
importance.
Title: Transradial versus transfemoral intervention in non-STsegment
elevation acute coronary syndrome patients undergoing percutaneous coronary
intervention: the Korean transradial intervention registry of 1 285 patients Authors: Min-Ho Lee, Duk Won Bang, Byung Won Park, Byung-Ryul Cho,
Seung-Woon Rha, Myung Ho Jeong, Junghan Yoon, Jon Suh, Kyoo-Rok Han, Min Su Hyon
From: Cardiovascular Journal of Africa, Vol 29,
Issue 6,November/December
Published: 2018
Pages: 374–380
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2018-047
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2018-047
Introduction: Although the implementation of
transradial intervention (TRI) has increased over the last few years, there are
limited data on the impact of TRI on efficacy and safety in patients with
non-ST-segment elevation acute coronary syndrome (NSTE-ACS). We sought to
compare one-year clinical outcomes and bleeding complications of TRI with those
of transfemoral intervention (TFI) in patients with NSTE-ACS.
Methods: The Korean TRI registry was a cohort of 20 centres from 2012 to 2015.
The primary efficacy endpoint was major adverse cardiovascular events (MACE),
defined as a composite of cardiac death (CD), non-fatal myocardial infarction
(MI) and repeat revascularisation (RR). Among the 1 319 patients with NSTE-ACS,
1 285 were finally analysed after excluding 34 due to lack of follow-up data.
The patients were divided into TRI and TFI groups according to the final access
site.
Results: At one-year follow up, the TRI group showed a significantly lower rate
of MACE, and a marginally significantly lower rate of CD than the TFI group in
the crude population. However, in propensity-score matched analysis, the rate of
MACE did not differ between the TRI and TFI groups. Regarding bleeding
complications, the TRI group was associated with significantly lower rates of
major bleeding in both the crude and matched populations. Independent predictors
of MACE were chronic kidney disease (CKD) and multi-vessel disease (MVD).
Conclusions: In patients with NSTE-ACS, TRI was associated with favourable
one-year clinical outcomes and lower bleeding complications compared to TFI.
Independent predictors of MACE were clinical and angiographic profiles (CKD,
MVD) rather than vascular access sites.
Title: Audit of transfusion of blood products in paediatric
congenital heart surgery on cardiopulmonary bypass
Authors: Caroline Tumelo Bayebaye, Michel
Kasongo Muteba, Palesa Motshabi Chakane
From: Cardiovascular Journal of Africa, Vol 29,
Issue, 6, November/December
Published: 2018
Pages: 381–386
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2018-048
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2018-048
Background: Cardiac surgery is associated with
peri-operative bleeding, which may result in the need for blood transfusion,
particularly in paediatric congenital cardiac surgery on cardiopulmonary bypass
(CPB). There is a necessity for regular auditing in order to improve practices.
Methods: Retrospective, contextual, descriptive data of 105 patients were
collected for the period January to December 2014.
Results: The median age of patients was four (1–6) years, weight was 13 (8.4–20)
kg, and mean lowest CPB haemoglobin level was 8.3 (1.5) g/dl. There was a
statistically significant difference in median red packed cell (RPC), platelet
and cryoprecipitate units per patient transfused across four RACHS
(risk-adjusted classification for congenital heart surgery) categories (p =
0.03, p = 0.0013, p = 0.0001, respectively). There was a statistically
significant correlation between transfused fresh frozen plasma units with CPB
time (r = 0.2634, p = 0.0199) and RPC units (r = –0.4654, p < 0.001).
Conclusion: Although no standardised transfusion guidelines were available,
overall transfusion of blood products was comparable to reported practices.
Title: Pre-eclampsia and the foetus:
a cardiovascular perspective
Authors: Ismail Bhorat
From: Cardiovascular Journal of Africa, Vol 29,
Issue, 6, November/December
Published: 2018
Pages: 387–393
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2017-039
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2017-039
Abstract: Pre-eclampsia is the leading cause of
perinatal morbidity and mortality. A full
understanding of the pathogenesis of this
enigmatic condition is essential if we are to
develop new prophylactic and therapeutic
interventions. Central to our understanding of
the pathogenesis of early-onset preeclampsia is
absolute utero-placental ischaemia, which is
lack of placental vascular transformation in
early pregnancy. By contrast, relative
utero-placental ischaemia, due to a mismatch
between utero-placental blood flow and increased
demand for nutrients occurring later in
pregnancy, may be central to the development of
late-onset pre-eclampsia. These pathogenic
mechanisms have advanced our understanding of
this condition, leading to better prediction,
screening and intervention modalities. Screening
for pre-eclampsia in the first and second
trimesters by investigating the maternoplacental
circulation and placental hormones could
identify a high-risk subgroup. The advantage of
screening in the first trimester is that a
prophylactic intervention is available in the
form of low-dose aspirin, if started before 16
weeks’ gestation in the high-risk group,
resulting in a substantial reduction in severe
early-onset pre-eclampsia, while identification
of a high-risk group in the second trimester
will lead to focused management in this group.
Using a combination of cardiac Doppler,
multi-vessel Doppler assessment of the foetal
circulation and biomarkers in established
pre-eclampsia in the third trimester could
predict adverse outcomes and guide clinicians to
timeous delivery. Hopefully, advances in our
understanding of this enigmatic disease will
lead to further prophylactic and new therapeutic
interventions.
Title: The Pan-African Society of Cardiology position paper on
reproductive healthcare for women with rheumatic heart disease
Authors: Ana Olga Mocumbi, Keila KF Jamal, Amam
Mbakwem, Maylene Shung-King, Karen Sliwa
From: Cardiovascular Journal of Africa, Vol 29,
Issue, 6, November/December
Published: 2018
Pages: 394–403
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2018-044
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2018-044
Abstract: This position paper summarises the
current knowledge on the epidemiology, diagnosis and management of women of
childbearing age with rheumatic heart disease (RHD) in Africa, as well as the
available data on their use of reproductive health services. The aim is to
provide guidance to health professionals on aspects of sexual and reproductive
health in women with RHD. It reviews the diagnosis, management and counselling
of women with RHD throughout their reproductive life. Additionally, this
publication discusses potential ways of integrating obstetric and cardiovascular
care at peripheral levels of the health systems, as a way of improving outcomes
and reducing maternal mortality rates related to cardiovascular disease in
Africa. Finally, the article proposes responses to fulfill the actual needs for
better reproductive health services and improvement in care for women with RHD.